Coursera, Inc. (NYSE: COUR) reported an insider stock sale this week when Alan B. Cardenas, the company’s senior vice president and general counsel, sold 9,710 shares of Coursera common stock at $5.92 per share on February 17, 2026, for a total of $57,483.
The sale was disclosed on a Form 4 filed with the Securities and Exchange Commission and was carried out under a Rule 10b5-1 trading plan that Cardenas adopted on September 4, 2025. The filing shows that the February 17 trade was one element of planned transactions executed under that prearranged schedule.
Two additional transactions on February 15, 2026, are listed in the filing as "disposals" to satisfy tax obligations. Those transactions totaled $60,632 at the same per-share price of $5.92. According to the filing, 9,759 shares were attributable to restricted stock units and 483 shares were tied to performance-based restricted stock units.
After these moves, Cardenas is reported to directly own 217,876 shares of Coursera common stock.
Separately, Coursera released its fourth-quarter 2025 financial results, reporting revenue of $197 million, a 10% increase year-over-year. The company’s revenue performance exceeded expectations cited by Telsey Advisory Group and topped the Street’s consensus of 7% growth. Adjusted EBITDA for the quarter rose by roughly 18% to about $11 million, beating Telsey’s estimate of $9 million.
In a strategic development disclosed alongside the results, Coursera and Udemy received early antitrust clearance from the U.S. Federal Trade Commission for their planned all-stock merger. The filing makes clear that this early clearance does not conclude the regulatory process; the transaction remains subject to additional approvals.
Analysts reacted with a range of adjustments to Coursera’s outlook. KeyBanc trimmed its price target to $10 from $12 but kept an Overweight rating. BMO Capital lowered its target to $8 from $11 and cited concerns about margin outlook while maintaining an Outperform rating. Telsey Advisory Group reiterated an Outperform rating and kept a $14 price target. Needham reaffirmed a Buy rating with a $10 target and noted the potential upside from a new platform fee on consumer gross margins in 2026.
The combination of insider selling, quarterly results that outperformed several estimates, and progress on regulatory clearance for the proposed merger has prompted a mixture of analyst optimism and caution reflected in the range of price-target revisions and maintained ratings.